Successful early treatment combining remdesivir with high-titer convalescent plasma among COVID-19-infected hematological patients.
Hematol Oncol
; 39(5): 715-720, 2021 Dec.
Article
in En
| MEDLINE
| ID: mdl-34396566
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Adenosine Monophosphate
/
Hematologic Neoplasms
/
Alanine
/
SARS-CoV-2
/
COVID-19
/
COVID-19 Drug Treatment
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Hematol Oncol
Year:
2021
Document type:
Article
Affiliation country:
Czech Republic